Following a rally to fresh all-time highs, Momo Inc (NASDAQ:MOMO) stock suffered a considerable setback. However, if you’ve been interested in buying MOMO, there’s …
Cantor analyst William Tanner is out pounding the table on shares of TherapeuticsMD (NASDAQ:TXMD), reiterating an Overweight rating and price target of $26, which implies an …
Shares of Amazon (NASDAQ:AMZN) spiked to an all-time high, up nearly 4% to $1,880, in early trading Friday. The reason?
Trevena’s (NASDAQ:TRVN) pain drug oliceridine is expecting an FDA decision coming November 2. Furthermore, the FDA has informed the company that it intends to …
Nomura analyst Romit Shah was out pounding the table on Tesla (NASDAQ:TSLA) Wednesday, reiterating a Buy rating and price target of $450, which implies an …
It’s been tough sledding for Kala Pharmaceuticals (NASDAQ:KALA) shareholders. The company’s share price has lost approximately 46% year-to-date due to the fact that …
Galmed Pharmaceuticals (NASDAQ:GLMD) shares are soaring nearly 20% in after-hours trading Wednesday, as the drug maker gets a vote of confidence from Cantor …
There’s little doubt that Facebook (NASDAQ:FB) has plenty of fans on Wall Street. Now you can add a new one to the list.
By Adam Fischbaum, After a couple of decades, it would seem that the idea of free trade or cooperative trade would be an …
Looking for a reason to buy shares of Nvidia (NASDAQ:NVDA)? How about three reasons, courtesy of FBN Securities analyst Shebly Seyrafi.
